BiomX Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by BiomX Inc. on July 30, 2025. The filing addresses corporate governance matters related to the upcoming 2025 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on shareholder meeting logistics and does not contain financial performance data.
Material Changes
The primary material change disclosed is the rescheduling of the 2025 Annual Meeting of Stockholders. The meeting date has been moved to October 16, 2025, which is more than 30 days from the anniversary of the 2024 Annual Meeting. Consequently, the record date for the meeting is set for August 22, 2025.
Guidance, Outlook, and Management Commentary
Management has established a deadline for stockholder proposals to be included in the proxy statement. Proposals must be received by 5:00 p.m. Eastern Time on August 15, 2025, in accordance with Rule 14a-8 of the Exchange Act. No financial guidance, risk factors, or unusual items were disclosed in this specific filing.
Key Facts for Investor Verification
- Annual Meeting Date: October 16, 2025.
- Record Date: August 22, 2025.
- Proposal Deadline: August 15, 2025, at 5:00 p.m. Eastern Time.
- Trading Symbol: PHGE (NYSE American).
- Financial Data: None provided in this filing; investors should refer to the most recent 10-K or 10-Q for financial metrics.